Navigation Links
New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation
Date:5/9/2011

MARLBOROUGH, Mass., May 9, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), announced its technology enables a Pulmonary Vein (PV) acute isolation rate of nearly 99%, with approximately 86% of PVs remaining persistently isolated after three months.  Additional research also suggests that 65% of patients achieve durable freedom from AF after a single procedure.

New clinical results supporting the safety and efficacy of the HeartLight System were presented at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions, in San Francisco, CA. The presentations included data from both a 200-patient international, multicenter clinical experience with the CardioFocus device (15 sites across four countries) and from a unique study that employed intracardiac diagnostic remapping on 56 paroxysmal AF patients, whether or not they were symptomatic, to determine the rate of persistent PV isolation.

"These recent clinical experiences support the promise of the HeartLight technology to help patients achieve lasting freedom from paroxysmal AF," commented Stephen Sagon, President and CEO of CardioFocus, Inc. "As shown by the robust data across multiple clinical centers, our proprietary technology, including endoscopic visualization, a compliant balloon catheter and the delivery of light energy, is helping to enhance the reproducibility and efficacy of atrial fibrillation ablation."

In the 200-patient study, titled "Pulmonary Vein Isolation Using the Visually-Guided Laser Balloon: The First 200-Patient Multicenter Clinical Experience" and presented on May 6th, researchers reported nearly 99% of all PVs were isolated following the HeartLight ablation procedure. Of the 107 patients that reached at least 6 months follow-up, 65% remained free from AF after a single ablation procedure. The procedure also demonstrated low complication ra
'/>"/>

SOURCE CardioFocus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002
2. Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session
3. Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings
4. Two New Studies in the British Medical Journal Find That Bayers Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot
5. Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies
6. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
7. New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions
8. MAP Pharmaceuticals to Present Data From LEVADEX® Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology
9. Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
10. Three Studies Presented at the 2011 SHEA Annual Scientific Meeting Show That the ICU Medical MicroCLAVE® Contributes to a Significant Decrease in Bacterial Transfer and Reduction in Bloodstream Infections
11. New Studies Show Clinical Advantages of Masimo Noninvasive Hemoglobin, PVI, and Perfusion Index in Critically-ill Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , September 2, 2015 ... market for global clinical trials review of H2, ... scenario with an objective to enhance decision making ... Complete report on Keratoconus market clinical trials ... companies, 10 institutes / government organizations and supported ...
(Date:9/1/2015)... Mass. , Sept. 1, 2015  Shareholder rights ... whether certain officers and directors of ConforMIS, Inc. (NASDAQGS: ... ConforMIS is a medical technology company that uses its ... joint replacement implants that are individually sized and shaped ... this press release on the law firm,s Shareholder Rights ...
(Date:9/1/2015)... , Sept. 1, 2015 On August 31, ... Jr. , issued a 123-page order in the first ... Medical Conserve metal-on-metal hip replacement devices are defective.[1]  ... judgment as to Plaintiff Robyn Christiansen,s claims for defective ... Court flatly rejected Wright Medical,s claim that the Medical ...
Breaking Medicine Technology:Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 2Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 3Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 4Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 5Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3
... LONDON, April 21, 2012 Medaxial, the ... won a Queen,s Award for Enterprise in recognition of ... for Enterprise are the UK,s most prestigious business accolade, ... select number of companies who have achieved outstanding results ...
... INC. (Nasdaq: PDEX ) announced today that ... of Chief Executive Officer, effective immediately.  The Company also ... positions with the Company and its subsidiaries, including his ... a member of the Company,s Board of Directors, effective ...
Cached Medicine Technology:Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 2Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 3Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer 2Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer 3
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in ... from everyday life changes can lead to very serious, life-altering events. Fortunately nature ... with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses of ...
(Date:9/1/2015)... , ... September 01, 2015 , ... From Aug. 17-21, ... and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community ... 65 adult counselors, some of whom work for Calvary, and two junior counselors who ...
(Date:9/1/2015)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) has once again ... 50 Report that recognizes companies that provide the best career opportunities for Hispanic women ... number 24 to 21 of the 50 Best Companies for Latinas. The LATINA Style ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... and prevent different malignancies. Some options for cancer treatment are available belonging ... which distinctive approach is necessary for effective treatment. Several molecules have been ...
Breaking Medicine News(10 mins):Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... Alzheimer,s disease that previously showed troubling side effects may ... The keys to the safety of the drug, ... it to patients with ApoE4, a gene mutation linked ...
... in the Fallopian tubes that carry eggs from a woman,s ... but this finding goes a long way towards explaining why ... pregnant," says Sean Ward, professor of physiology and cell biology, ... the study. Ward,s study was recently published ...
... A new drug targeting the PI3K gene in patients ... early phase I investigational study conducted at Virginia G. ... by oncologist Dr. Daniel D. Von Hoff at the ... Oncology (ASCO). The drug under investigation, GDC-0941, manufactured ...
... Beth Israel Deaconess Medical Center (BIDMC) has been awarded ... Infectious Diseases (NIAID), part of the National Institutes of ... in Nonhuman Primates. The five-year grant totals $36 million. ... MD, PhD, a Professor of Medicine at Harvard Medical ...
... WEDNESDAY, July 20 (HealthDay News) -- The meteorological monster -- ... throttled much of the United States from the Southwest to ... ushering in oppressive humidity, temperatures in the high 90s and ... wave, blamed for as many as 13 deaths in the ...
... with a serious genetic blood disorder are not getting the ... to sickness. Research funded by the Economic and ... of York and Loughborough University reveals that most children with ... in catching up on absences from class. Sickle ...
Cached Medicine News:Health News:Experimental Drug Might Help Fight Alzheimer's After All 2Health News:Experimental Drug Might Help Fight Alzheimer's After All 3Health News:Nevada School of Medicine researcher finds caffeine consumption, female infertility link 2Health News:TGen, Virginia G. Piper Cancer Center studying new breast cancer drug 2Health News:'Heat Dome' Continues to Throttle U.S. 2Health News:'Heat Dome' Continues to Throttle U.S. 3Health News:Schools failing pupils with sickle cell disease 2
The First Check Home Drug Test is the first over-the counter, FDA approved home drug test that provides immediate information about the possible use of prescription drugs....
PediaVision LLC is a life sciences company dedicated to solving the critical problem of undiagnosed vision problems affecting children worldwide....
... the treatment of presbyopia, a condition that affects ... patients. , Presbyopia results from the gradual loss ... eye as a person ages, making the lens ... eye has a harder time focusing on objects ...
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
Medicine Products: